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OBJECTIVES We hypothesized that neonatal long QT syndrome (LQTS) with 2:1 atrioventricular block
(AVB) could be related to HERG mutations.
BACKGROUND Early onset of LQTS is rare but carries a high risk of life-threatening events such as
ventricular arrhythmias and conduction disorders. There are no data on possible gene
specificity.
METHODS We analyzed the characteristics and outcomes of 23 neonate probands from our LQTS
population. Samples of DNA were available in 18 cases.
RESULTS Long QT syndrome was diagnosed because of corrected QT interval (QTc) prolongation (mean
QTc of 558  62 ms) and neonatal bradycardia attributable to sinus bradycardia (n  8) or 2:1
AVB (n  15). Symptoms included syncope (n  2), torsades de pointes (n  7), and
hemodynamic failure (n  6). Three infants with 2:1 AVB died during the first month of life.
During the neonatal period, all living patients received beta-blockers (BB) and 13 had a
combination of BB and permanent cardiac pacing. Under treatment, patients remained asymp-
tomatic, with a mean follow-up of seven years. Mutations were identified in HERG (n  8) and
KCNQ1 (n 8), and one child had three mutations (HERG, KCNQ1, and SCN5A). Conduction
disorders were associated with LQT2, whereas sinus bradycardia was associated with LQT1.
CONCLUSIONS Two-to-one AVB seems preferentially associated with HERG mutations, either isolated or
combined. Long QT syndrome with relative bradycardia attributable to 2:1 AVB has a poor
prognosis during the first month of life. In contrast, sinus bradycardia seems to be associated
with KCNQ1 mutations, with a good short-term prognosis under BB therapy. (J Am Coll
Cardiol 2004;43:826–30) © 2004 by the American College of Cardiology Foundation
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ahe congenital long QT syndrome (LQTS) is a poten-
ially lethal cardiac disease caused by mutations in specific
on channels (1). Bradycardia is considered as a diagnos-
ic criterion (2) and is also associated with a risk of
ardiac events (3). A lower than normal heart rate can be
aused by slow sinus rhythm or impaired atrioventricular
AV) conduction, mainly 2:1 AV block (AVB). This
atter form is rare and usually manifests itself before birth
r during the neonatal period (4 –9). The prognosis is
oor, with a 50% death rate before six months (5,7). So
ar, three cases of neonatal LQTS with 2:1 AVB have
een related to homozygous HERG mutations (8 –11).
e hypothesized that neonatal LQTS with 2:1 AVB
ould be related to HERG mutations.
ETHODS
tudy population. From our LQTS population, we
dentified 23 neonate probands with ventricular rates
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he basis of prolongation of ventricular repolarization
corrected QT interval [QTc] 460 ms, according to
azett’s formula) (12). Each patient underwent a clinical
valuation and cardiovascular examination, including a
2-lead electrocardiogram (ECG) and 24-h Holter re-
ording. At the time of the study, none of the parents
ere known to have LQTS. In 18 cases, blood samples
ere obtained for genotyping after written consent from
he parents, in accordance with the protocol, as approved
y the local Ethics Committee.
utation analysis. Genomic deoxyribonucleic acid was
xtracted from blood samples using the standard procedure.
reviously published primer pairs were used to amplify all
xons of KCNQ1, HERG, KCNE1, and SCN5A from
enomic DNA (13). Abnormal conformers were identified
ither by polymerase chain reaction–single strand confor-
ation polymorphism or by using denaturing high-
erformance liquid chromatography in case of negative
esults. The corresponding exons were reamplified and
equenced by the dideoxynucleotide chain termination
ethod with fluorescent dideoxynucleotides on an ABI-
rism 377 DNA sequencer (Applera, Applied Biosystems).
hen a mutation in one LQTS gene was identified, the
ther LQTS genes were also screened to eliminate associ-
ted mutations. In case of de novo mutations, biologic
aternity was confirmed by DNA analysis. A control group
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March 3, 2004:826–30 2:1 AVB in Neonatal LQTSf 100 healthy and unrelated subjects was used to exclude
he possibility of the novel detected mutations being DNA
olymorphisms.
tatistical analysis. Data are expressed as the mean value
SD. Mean QTc and sinus rate values were compared
sing the unpaired Student t test, with p  0.05 considered
s statistically significant.
ESULTS
linical results. Long QT syndrome was diagnosed at a
ean age of 4  2 days in full-term infants (14 males) on the
rounds of isolated bradycardia (n  13 [57%]) or torsades de
Abbreviations and Acronyms
AV  atrioventricular
AVB  atrioventricular block
BB  beta-blocker/blocking
QTc  corrected QT interval
ECG  electrocardiogram
LQTS  long QT syndrome
able 1. Clinical and Genetic Characteristics of Neonates With 2
Patient
Number/Gender
Circumstances of
Diagnosis
ECG QTc (ms)
AR/VR
(beats/min)
1/M Syncope 620
110/55
2/M Fetal bradycardia 520
120/60
3/M Syncope 630
120/60
4/F Fetal bradycardia, TDP 530
150/75
5/M Neonatal bradycardia 640
120/60
6/F Fetal bradycardia, TDP 560
120/60
7/M Heart failure 560
120/60
8/F Fetal bradycardia, collapse 580
TDP 140/70
9/M Neonatal bradycardia 520
120/60
10/F Fetal bradycardia, VF, 527
cardiac arrest at day 1 140/70
11/F Neonatal bradycardia 490
140/70
12/M Fetal arrhythmia, collapse 700
TDP, VT 90/45
13/F Neonatal bradycardia, 600
heart failure, collapse,
VT
100/50
14/F Fetal bradycardia, TDP, 544
heart failure 140/70
15/M Fetal bradycardia 680
110/55
R  atrial rate; AS  asymptomatic; AVB  atrioventricular block; ECG  electr
Tc  corrected QT interval; SD  sudden death; TDP  torsades de pointes; VF  vointes (n  7). In 10 other cases, QT prolongation was
videnced on the surface ECG in neonates referred for loss of
onscious (n  2), cardiac arrest (n  1), or hemodynamic
ailure (n  5) (Table 1). In contrast to neonates with relative
radycardia attributable to AVB, all neonates with sinus
radycardia were asymptomatic (Table 2). Electrocardiography
as performed because of a lower than normal heart rate at
irth and evidenced a prolonged QTc (mean 558  62 ms).
he QTc, according to Fredericia’s formula, was 510 56 ms.
t the time of diagnosis, before any therapy, the mean
entricular rate was slow (110 23 beats/min), compared with
ealthy newborns (12), because of sinus bradycardia (n 8) or
:1 AVB (n  15). In 12 cases, bradycardia was also detected
renatally at a mean gestational age of 30 weeks during
ystematic cardiofetal monitoring. Fetal echocardiography was
ubsequently performed in only two cases showing 2:1 con-
uction associated with fast, irregular ventricular activity, sug-
esting ventricular tachycardia in Patient 12 and a slow, regular
:1 rhythm in Patient 21. In patients with AV conduction
isorders, Holter recordings revealed frequency-dependent
onduction anomalies with episodes of 2:1 AVB occurring
trioventricular Block
Initial
Therapy
Outcome
Follow-Up Genotype
ropranolol and PM Death at 3 weeks of No DNA
sepsis
ropranolol AS at 14 years No mutation identified
cebutolol AS at 10 years No DNA
ropranolol Lost to follow-up at No DNA
9 months
ropranolol and PM AS at 17 years No DNA
one SD at 1 month No DNA
ropranolol and PM SD at 9 days, HERG G604S by MT
3 days after
withdrawal
ropranolol and PM AS without PM at HERG T613M by MT
23 years
ropranolol AS at 21 years HERG T613M by MT
ropranolol and PM AS without PM at HERG S621N by MT
10 years
ropranolol and PM AS at 1 year HERG D501N by MT
ropranolol 10-year runs of KCNQ1 R555H,
TDP under
nadolol and PM
HERG R835W,
SCN5A L619F
ropranolol and PM AS at 6 months HERG M645V
(de novo mutation)
ropranolol and PM AS at 3 months HERG G628S
(de novo mutation)
ropranolol and PM AS without PM at HERG Y493C
9 years (de novo mutation)
ographic; F  female; M  male; MT  maternal transmission; PM  pacemaker;:1 A
P
P
A
P
P
N
P
P
P
P
P
P
P
P
P
ocardi
entricular fibrillation; VR  ventricular rate; VT  ventricular tachycardia.
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2:1 AVB in Neonatal LQTS March 3, 2004:826–30hen the atrial rate increased above 150 beats/min without any
entricular arrhythmia (Fig. 1). During sequences of 1:1
onduction, a notched T-wave morphology was demonstrated.
ompared with neonates with sinus bradycardia, neonates
ith 2:1 AVB had a significantly higher sinus rate (86  12
eats/min vs. 117 18 beats/min, respectively; p 0.001) and
significantly longer mean QTc (516  36 ms vs. 580  63
s, respectively; p  0.05). Families of LQTS neonate
robands were screened for LQTS. A family history was
vailable in all cases of LQTS with sinus bradycardia. In seven
ases, a prolonged QTc (mean 458 13 ms) was discovered in
ne of the parents, which was always the mother. Only one
oman had experienced syncope during childhood. A familial
istory was available in 10 of 15 cases of 2:1 AVB and was
egative in parents and siblings of patient nos. 2, 13, 14, and 15
ith normal QTc intervals. In six families, a prolonged QTc
mean 492  24 ms; n  5) was discovered in the mother,
symptomatic in all cases. However, the maternal aunt of
atient 11 died suddenly at the age of 16 years.
reatment and follow-up. Three infants with 2:1 AVB
ied before one month of age: one case of sepsis in a child
ith a pacemaker; one case after interruption of pacing
ue to a loss of capture; and the last case in the absence
f treatment because of parent refusal. Beta-blocking
BB) therapy was initiated with propranolol at a mean
osage of 1 mg/kg per day in all neonates and was titrated
o 3 mg/kg per day. In patients with 2:1 AVB, there was
mean 20% decrease in sinus rate, and maximal heart
ates were below 150 beats/min. In nine of the patients
ith 2:1 AVB, propranolol was combined with perma-
ent cardiac pacing. The mode of pacing was VVI for
even of nine cases and DDD for two of nine cases. None
f the neonates with sinus bradycardia required a pace-
aker under propranolol at a mean dose of 3 mg/kg.
inus rhythm decreased from 86  12 to 80  10
able 2. Clinical and Genetic Characteristics of Neonates With S
Patient
Number/Gender
Circumstances of
Diagnosis
ECG QTc (ms)
VR (beats/min)
16/M Fetal bradycardia 527
65
17/M Neonatal bradycardia 500
90
18/F Fetal bradycardia 480
90
19/M Neonatal bradycardia 460
95
20/F Fetal bradycardia 550
90
21/M Fetal bradycardia 545
94
22/M Neonatal bradycardia 560
95
23/M Fetal bradycardia 503
69
 genomic; ins  insertion; other abbreviations as in Table 1.eats/min during the first month of life. During follow- mp, propranolol was switched to nadolol by the age
wo years, and the dosage was adjusted to reach a
aximal heart rate 150 beats/min in children under 10
ears and 130 beats/min in children older than 10
ears. All living children were asymptomatic under nado-
ol (50 mg/m2/day) during a mean follow-up of seven
ears.
enetic results. We identified eight mutations in KCNQ1
nd eight mutations in HERG (Tables 1 and 2). In one
hild presenting initially with 2:1 AVB and severe ventric-
lar arrhythmias, three mutations were identified: one in
CNQ1 (R555C) and one in SCN5A (L619F), both inher-
ted from the mother, and the third in HERG (R835W),
nherited from the father. Mutations were de novo in five
ases (HERG: n  4; KCNQ1: n  1). A novel hot spot in
CNQ1 with R231C was identified in three patients. Two
ovel nonsense mutations were identified in KCNQ1
K422fsX and L175fsX), as well as a novel missense
utation (A590T). Mutations in HERG were known in six
ases and novel in two cases (D501R and R835W). In the
5 cases of AVB, DNA samples were available in 10 infants,
ith mutations identified in HERG in nine of 10 cases.
amples of DNA were available in all neonates with sinus
radycardia, and mutations in KCNQ1 were identified in all
ight cases. Interestingly, all HERG mutations were found
n cases with relative bradycardia attributable to AV con-
uction disorders, whereas isolated mutations in KCNQ1
ere found in neonates with sinus bradycardia.
ISCUSSION
e provide evidence that AV conduction disorders in
eonatal forms of LQTS are preferentially associated with a
ERG mutation, either isolated or combined, whereas
ersistent sinus bradycardia is associated with KCNQ1
Bradycardia
itial
erapy
Outcome
Follow-Up Genotype
ranolol AS at 8 yrs KCNQ1 R231C (de novo mutation)
ranolol AS at 7 yrs KCNQ1 R174H by MT
ranolol AS at 4 yrs KCNQ1 g.1258 ins A by MT
ranolol AS at 6 yrs KCNQ1 A590T by MT
ranolol AS at 2 yrs KCNQ1 G325R by MT
ranolol AS at 2 months KCNQ1 R231C by MT
ranolol AS at 3 yrs KCNQ1 g.dup524–534 by MT
utolol AS at 2 yrs KCNQ1 R231C by MTinus
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March 3, 2004:826–30 2:1 AVB in Neonatal LQTSardia attributable to 2:1 AVB has a severe prognosis,
ainly during the first month of life.
As of today, little is known about the genotype of patients
ith LQTS and 2:1 AVB. Recent reports of LQTS with
unctional 2:1 AVB have been related to homozygous
utations in HERG (8–11) or SCN5A (14). Three infants
ith homozygous HERG mutations had a prolonged QTc,
ith functional 2:1 AVB with one sudden death in utero,
hereas heterozygous carriers in the family had a normal
henotype (8–11). The child with a homozygous SCN5A
utation was not symptomatic during the first month of life
nd was older at diagnosis (14). In our series, we also found
hat neonates with AVB had mutations in HERG, but at
igure 1. Electrocardiographic (A) and Holter (B) recordings of a one-day
he Holter recording showed 1:1 sinus rhythm periods, thus demonstrating
ointed to a mutation in HERG, which was identified.he heterozygous state (n  8) or combined with mutations sn other LQTS genes (n  1). However, any genetic defect
ssociated with electrophysiologic anomalies producing ma-
or ventricular repolarization prolongation associated with a
ast sinus rate could promote such a phenotype. In contrast,
e did not have evidence of any AV conduction disorders in
ur LQT1 neonates, even in those with the longest QTc.
his could be explained by the fact that in our population,
eonates with mutations in KCNQ1 have slower sinus rates
han those with mutations in HERG. In the case of relative
inus bradycardia, the P wave occurs after the end of the
entricular refractory period, even when there is a major
rolongation of the T wave, thus avoiding functional 2:1
VB. The underlying molecular defect associated with
neonate with bradycardia attributable to 2:1 atrioventricular block (AVB).
the AVB was intermittent. Furthermore, the notched T-wave morphology-old
thatinus bradycardia remains to be explored. There is evidence
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2:1 AVB in Neonatal LQTS March 3, 2004:826–30hat LQT1 patients have slower heart rates, particularly
uring effort. A diminished heart rate response to exercise
as been evidenced in older LQT1 patients compared with
QT2 patients (15). It appears that 2:1 AVB is not related
o mutations in KCNQ1, as opposed to mutations in
ERG at the heterozygous or the homozygous state or in
CN5A at the homozygous state in an older child (14).
espite the role of SCN5A in conduction disorders in older
atients, we have not yet identified isolated mutations in
his gene in our neonate population with bradycardia.
Long QT syndrome with 2:1 AVB is rare, with an
ncidence of 4% reported in pediatric series and a high
ortality rate (5). The death rate in our population was
ower (3 [13%] of 23 patients), probably as a result of
renatal diagnosis and aggressive initial therapy combin-
ng BB and pacemaker implantation in 60% of the 2:1
VB neonates. Among the three deaths, one occurred in
he total absence of treatment and the two others under
B therapy, but in the context of sepsis in one case and
ith pacing failure in the other case. These patients were
ot given the a full therapeutic option and were the first
f our series. Management of such patients has been
mproved since. We confirm that LQTS in neonates with
:1 AVB is malignant, as attested by the high rate of
ardiac arrest or hemodynamic failure (26%) and torsades
e pointes (30%), compared with reported pediatric series
f older patients of a mean age of 6.8  5.6 years (9%
ardiac arrest, 6% torsades de pointes) (16). In contrast,
nfants with isolated sinus bradycardia appear to have a
ore benign initial prognosis under initial BB therapy.
owever, one neonate with LQTS and torsades de
ointes with neither AVB nor bradycardia died suddenly
t nine weeks under BB therapy (17).
onclusions. Atrioventricular conduction disorders in
eonates with LQTS seem to be associated preferentially
ith a HERG mutation, either isolated or combined, as
pposed to persistent sinus bradycardia, which seems to
e associated with KCNQ1 mutations. Early onset of
QTS with bradycardia attributable to 2:1 AVB has a
oor prognosis, mainly during the first month of life, and
equires pacemaker implantation combined with BB.
hese findings should be confirmed by larger collabora-ive studies.eprint requests and correspondence: Dr. Jean-Marc Lupogla-
off, Cardiologie, Hoˆpital Robert Debre´-48, Boulevard Se´rurier,
5019 Paris, France. E-mail: jean-marc.lupoglazof@rdb.ap-hop-
aris.fr.
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